Common Comorbidities Seen in Adolescents With Attention-Deficit/Hyperactivity Disorder
Joel Young(Dalhousie University)
Cited by 36
Related Papers
Long-Term Safety and Effectiveness of Lisdexamfetamine Dimesylate in Adults With Attention-Deficit/Hyperactivity Disorder
|CNS Spectrums|2009|93
A Randomized, Placebo-Controlled Trial of Guanfacine Extended Release in Adolescents With Attention-Deficit/Hyperactivity Disorder
|Journal of the American Academy of Child & Adolescent Psychiatry|2015|63
Once-Daily Treatment With Atomoxetine in Adults With Attention-Deficit/Hyperactivity Disorder
|Clinical Neuropharmacology|2011|61
Discontinuity in the Transition from Pediatric to Adult Health Care for Patients with Attention–Deficit/Hyperactivity Disorder
|Postgraduate Medicine|2012|49
Adult Attention-Deficit/Hyperactivity Disorder Diagnosis, Management, and Treatment in the <em>DSM-5</em> Era
|The Primary Care Companion For CNS Disorders|2016|45